Evidence map›Paper›PMID 34917649›Full record

ArticleFrontiers in molecular biosciences2021

A Novel Diagnostic Biomarker, PZP, for Detecting Colorectal Cancer in Type 2 Diabetes Mellitus Patients Identified by Serum-Based Mass Spectrometry.

Jiayue Yang, Weigang Fang, Wenjun Wu, Zhen Tian, Rong Gao, Lu Yu, Dayang Chen, Xiaohua Weng, Shengwei Zhu, Cheng Yang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in molecular biosciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Jiayue YangDepartment of Endocrinology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China.
Weigang FangDepartment of Gastroenterology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China.
Wenjun WuDepartment of Endocrinology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China.
Zhen TianDepartment of Clinical Laboratory, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China.
Rong GaoDepartment of Clinical Laboratory, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China.
Lu YuDepartment of Endocrinology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China.
Dayang ChenDepartment of Gastroenterology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China.
Xiaohua WengDepartment of Endocrinology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China.
Shengwei ZhuDepartment of Endocrinology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China.
Cheng YangDepartment of Gastroenterology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China.
Wuxi People's Hospital · CNNanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkercolorectal cancermass spectrumPZPtype 2 diabetes mellitus

Identifiers

PMID34917649
PMCPMC8670180
OpenAlexW3216764892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.